Digital PCR (dPCR) is an increasingly popular manifestation of PCR that offers a number of unique advantages when applied to preclinical research, particularly when used to detect rare mutations and ...
Traditionally, test developers have used quantitative PCR (qPCR) to create highly specific laboratory-developed tests (LDTs). However, digital PCR (dPCR) is emerging as the preferred technology for ...
Even standard polymerase chain reaction (PCR) technology should, in principle, boost weak mutant signals so that they may emerge from all the genomic noise emitted by wild-type sequences. Yet standard ...
SAN DIEGO, October 1, 2023 — Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence ...
Targeted therapies take advantage of specific mutations in tumour DNA, but cancer cells can find ways to thwart them. Improving oncologists’ ability to quickly detect whether a tumour has developed ...
A digital polymerase chain reaction (dPCR) test and a sequencing test for HPV, the primary cause of cervical cancer, were compared in the study, and it was discovered that both were equally effective ...
Farmington, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The Global Digital Polymerase Chain Reaction (dPCR) Market Was Valued At USD 508.82 Million In 2021 And Is Projected To Reach USD 1,305.3 Million By 2030, ...
Dublin, Sept. 27, 2021 (GLOBE NEWSWIRE) -- The "Polymerase Chain Reaction Market Size, Share & Trends Analysis Report By Type, By Product (Instruments, Consumables & Reagents), By Application, By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback